Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release

被引:35
作者
Cervia, D
Fiorini, S
Pavan, B
Biondi, C
Bagnoli, P
机构
[1] Univ Pisa, Dipartimento Fisiol & Biochim G Moruzzi, I-56127 Pisa, Italy
[2] Univ Ferrara, Dipartimento Biol, Sez Fisiol Gen, I-44100 Ferrara, Italy
关键词
peptide receptors; agonists; antagonist; intracellular Ca2+; cAMP; PLA(2)/AA; cell culture; fluorimetry; biochemical dosages; somatostatin;
D O I
10.1007/s00210-001-0509-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The somatotropin release-inhibiting factor somatostatin-14 (SRIF) is known to activate distinct receptor subtypes (sst(1-5)). In rat pituitary tumor cells (GC cells), sst(2) but not sst(1) receptors mediate the SRIF-induced inhibition of intracellular concentration of Ca2+ ([Ca2+](i)) and are negatively coupled to cAMP-dependent pathways. In the present study, transduction mechanisms coupling distinct SRIF receptors to their specific functional role were investigated with the use of both SRIF agonists with well-known affinity at individual SRIF receptors and the sst(2) receptor antagonist L-Tyr(8) isomer of Cyanamid 154806 (CYN-154806). Our results demonstrate that sst(1) and sst(2) receptors are coupled to distinct signaling pathways in GC cells. In particular, sst(2) receptors are negatively coupled to the cAMP-dependent pathway and this pathway is partially responsible for the sst(2) receptor-mediated inhibition of [Ca2+](i). In addition, sst(1) and sst(2) receptors are both coupled to a decrease of arachidonic acid (AA) release with an efficacy similar to that of SRIF, suggesting that SRIF reduces AA release through either a partial activation of both receptors or the activation of one at a time. This finding is important given the well-accepted role for phospholipase A(2) (PLA(2)) as a positive signaling component in transduction pathways of SRIF receptors. sst(1) and sst(2) receptor negative coupling to PLA(2)/AA pathways does not seem to be implicated in the SRIF-induced inhibition of [Ca2+](i). The possible role for the SRIF-mediated inhibition of AA release in GC cell function remains to be elucidated.
引用
收藏
页码:200 / 209
页数:10
相关论文
共 71 条
[1]   Calcium-dependent phospholipase A2 mediates the production of endothelium-derived hyperpolarizing factor in perfused rat mesenteric prearteriolar bed [J].
Adeagbo, ASO ;
Henzel, MK .
JOURNAL OF VASCULAR RESEARCH, 1998, 35 (01) :27-35
[2]   Somatostatin receptor-mediated arachidonic acid mobilization: evidence for partial agonism of synthetic peptides [J].
Alderton, F ;
Fan, ZPD ;
Humphrey, PPA .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (03) :760-766
[3]  
AriasDiaz J, 1997, EUR J SURG, V163, P619
[4]   Arachidonic acid reversibly enhances N-type calcium current at an extracellular site [J].
Barrett, CF ;
Liu, LW ;
Rittenhouse, AR .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (05) :C1306-C1318
[5]   Activation of calcium channels by cAMP in STC-1 cells is dependent upon Ca2+ calmodulin-dependent protein kinase II [J].
Basavappa, S ;
Mangel, AW ;
Scott, L ;
Liddle, RA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (03) :699-702
[6]  
Bass RT, 1996, MOL PHARMACOL, V50, P709
[7]  
Bass RT, 1997, MOL PHARMACOL, V51, P170
[8]  
BITO H, 1994, J BIOL CHEM, V269, P12722
[9]   HYPOTHALAMIC POLYPEPTIDE THAT INHIBITS SECRETION OF IMMUNOREACTIVE PITUITARY GROWTH-HORMONE [J].
BRAZEAU, P ;
VALE, W ;
BURGUS, R ;
LING, N ;
BUTCHER, M ;
RIVIER, J ;
GUILLEMIN, R .
SCIENCE, 1973, 179 (4068) :77-79
[10]   Species differences between male rat and ram pituitary somatostatin receptors involved in the inhibition of growth hormone secretion [J].
Briard, N ;
Dutour, A ;
Epelbaum, J ;
Sauze, N ;
Slama, A ;
Oliver, C .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 137 (05) :545-555